Status:
RECRUITING
Trans-nasal Endoscopy for Bariatric Patients
Lead Sponsor:
Christopher C. Thompson, MD, MSc
Collaborating Sponsors:
EvoEndo, Inc.
Conditions:
Obesity
Obesity, Morbid
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest curren...
Detailed Description
Oral sedated endoscopy of the upper gastrointestinal tract as Esophagogastroduodenoscopy (EGD) has been time tested and effective, but poses enhanced risk in the bariatric population. In the adult pop...
Eligibility Criteria
Inclusion
- Patient 18 years of age and less than 90 years of age with clinically referred for esophagoscopy, gastroscopy, or esophagogastroduodenoscopy (EGD)
- Cared for in metabolic and bariatric clinic
Exclusion
- Patient \<18 years of age
- Medically contraindicated to perform EGD or TNE
- Inability to provide informed consent
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06200961
Start Date
December 1 2025
End Date
June 1 2027
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115